Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-MSCs for Surgery-Induced Lung Injury in IHD Patients
NCT04996966Phase 1Recruiting
- Sponsor
- Shanghai East Hospital
- Start
- Aug 2021
- Primary completion
- Dec 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised trial of human umbilical cord derived mesenchymal stem cells in not applicable; "lung injury" is not a specific disease (2 arms), sponsored by Shanghai East Hospital. Primary endpoint: Oxygenation Index. Started Aug 2021; status: recruiting.
02
Drugs
human umbilical cord derived mesenchymal stem cells
03
Conditions
not applicable; "lung injury" is not a specific disease
Beyond the preview
Go deeper on NCT04996966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04996966.